New membrane patch aims to heal stubborn bedsores faster
NCT ID NCT07126886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single-layer amniotic membrane (a thin tissue from donated placenta) plus standard wound care helps close nonhealing pressure ulcers better than standard care alone. About 100 adults with stage 3 or 4 pressure sores on the trunk will be followed for 20 weeks. The main goal is to see if more wounds close completely with the membrane treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESSURE AREA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Serena Group- Monroeville
RECRUITINGMonroeville, Pennsylvania, 15146, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simpler air mattress may prevent bedsores just as well — trial puts it to the test
- New imaging device aims to improve wound measurement
- New hope for bedsores: 2,000-Patient trial tests advanced wound matrices
- New mineral spray shows promise for faster wound healing
- Hidden danger: blood clot prevention device may cause pressure sores
- Can fatty acids beat dressings to stop bedsores in prone patients?